Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study

Anna Paola Batocchi, E Cocco, C Sardu, P Gallo, R Capra, Mp Amato, M Trojano, A Uccelli, Mg Marrosu, Femims Group

Risultato della ricerca: Contributo in rivistaArticolo in rivista

56 Citazioni (Scopus)

Abstract

Improved prognosis in women with multiple sclerosis (MS) undergoing immunosuppressive treatment with mitoxantrone (MITO) has led to an increased interest in the effect of such treatments on fertility. FErtility and Mitoxantrone In MS (FEMIMS) is a collaborative retrospective study aimed at evaluating the impact of MITO treatment on fertility in women with MS.
Lingua originaleEnglish
pagine (da-a)1225-1233
Numero di pagine9
RivistaMultiple Sclerosis
Volume14
DOI
Stato di pubblicazionePubblicato - 2008
Pubblicato esternamente

Keywords

  • Immunosuppressive Agents
  • Infertility, Female
  • Mitoxantrone
  • Multiple Sclerosis

Fingerprint

Entra nei temi di ricerca di 'Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study'. Insieme formano una fingerprint unica.

Cita questo